ABOUT EXERKINE
Exerkine Corporation is a nutra-pharmaceutical company pioneering therapies that address the root drivers of human health and disease. Our work is grounded in the latest advances in mitochondrial science, cell metabolism, exercise physiology, and nutrition; disciplines that are reshaping how conditions are understood and treated. At the core of our approach is a robust and expanding patent portfolio of interventions designed to repair and optimize the body’s natural biological systems. Human health is governed by interconnected pathways; targeting a single mechanism is rarely enough. Exerkine’s patented technologies target multiple shared pathophysiological pathways, enabling synergistic treatment effects while minimizing unintended side effects. Our proprietary technology enhances innate biological processes rather than overriding them. By strategically targeting pathways implicated in both rare genetic disorders and widespread acquired conditions, we are developing safe, effective therapeutics that address disease at its origin.
OUR FOUNDER
MARK TARNOPOLSKY, MD, PHD, FRCP(C)
Dr. Mark Tarnopolsky is a neurometabolic and neuromuscular disease clinician-scientist and internationally recognized authority on the role of exercise and nutrition in muscle disease, mitochondrial genetic disorders, aging, athletic performance, and obesity.
He founded Exerkine in 2013 to translate decades of human and mechanistic research into a new class of mitochondrial-targeted therapies aimed at improving outcomes in both genetic and acquired conditions. His work bridges academic research, clinical medicine, and product development.
Dr. Tarnopolsky holds an endowed chair in Neuromuscular Disorders at McMaster Children’s Hospital and Hamilton Health Sciences Foundation and serves as Professor of Pediatrics and Medicine and Director of the Neuromuscular and Neurometabolic Clinic at McMaster Children’s Hospital.
He has authored more than 570 peer-reviewed publications (h-index 149) and is among the most cited researchers globally in mitochondrial and neuromuscular medicine. His career contributions have been recognized by major international organizations, including the International Biochemistry of Exercise Association and the American College of Sports Medicine.
In parallel with his academic career, Dr. Tarnopolsky has spent over 20 years consulting for the pharmaceutical industry and previously co-founded and served as Chief Scientific Officer of Life Science Nutraceuticals, bringing translational and commercial rigor to Exerkine’s development strategy.
